Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Chardan Capital Downgrades Oncorus to Neutral

Chardan Capital Downgrades Oncorus to Neutral

Chardan Capital analyst Matthew Barcus downgrades Oncorus (NASDAQ:ONCR) from Buy to Neutral.

byBenzinga Newsdesk

December 1, 2022

1 minute read

Chardan Capital analyst Matthew Barcus downgrades Oncorus (NASDAQ:ONCR) from Buy to Neutral.

ABM Industries Inc Sees FY23 EPS $3.40-$3.60 Vs $3.70 Est.

By Benzinga Newsdesk

December 13, 5:05 PM

ABM INDUSTRIES INCORPORATED AND SUBSIDIARIES 2023 GUIDANCE Year Ending October 31, 2023 Reconciliation of Estimated Net Income per Diluted Share to Estimated Adjusted Net Income per Diluted

ABM

Legal
News

Walmart To Pay $215M To Resolve Claims That It Fueled Opioid Epidemic In Florida

By Benzinga Newsdesk

October 20, 3:09 PM

-Reuters

WMT

Amazon Leverages Generative AI for Holiday Ad Boost, Targeting 160M Prime Subscribers

By Anusuya Lahiri

October 30, 8:35 AM

Amazon.Com Inc (NASDAQ: AMZN) looks to utilize generative AI as a strategic tool

AMZN

PepsiCo To Surge Over 12%? Plus Morgan Stanley Sees $420 For This Stock

By Lisa Levin

October 13, 8:31 AM

Wedbush boosted the price target on PepsiCo, Inc. (NASDAQ: PEP) from $185 to $190. Wedbush analyst Gerald Pascarelli maintained an Outperform rating on the stock. PepsiCo shares rose 0.1% to $169.56 in pre-market trading.

AMAT

Chardan Capital Downgrades Oncorus to Neutral

Related Posts

ABM Industries Inc Sees FY23 EPS $3.40-$3.60 Vs $3.70 Est.

Walmart To Pay $215M To Resolve Claims That It Fueled Opioid Epidemic In Florida

Amazon Leverages Generative AI for Holiday Ad Boost, Targeting 160M Prime Subscribers

PepsiCo To Surge Over 12%? Plus Morgan Stanley Sees $420 For This Stock